Announcement on Subsidiary's Passing GMP Compliance Inspection
Filed with SSE · · 2 pages · Chinese
Beijing Foyou Pharma Co., Ltd. on 6ix
Earlier from Beijing Foyou Pharma
- Announcement on Obtainment of Drug Registration Certificate for Icosapent Ethyl Soft Capsules
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials
- Announcement on Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
- Announcement on Obtaining Drug Registration Certificate for Bromhexine Hydrochloride Oral Solution
- Announcement on Change of the Signing Accountant
Later from Beijing Foyou Pharma
- Announcement on Obtaining the Notice of Approval for Drug Clinical Trials of Bimatoprost Ointment
- Announcement on Obtaining Drug Registration Certificate for Dibutyrosine Adenosyl Methyltransferase Enteric-coated Tablets
- Announcement on 2025 Annual Profit Distribution Plan
- Announcement on Obtaining Drug Registration Certificate for Pioglitazone-Metformin Tablets (I)
- Announcement on Convening the Q1 2026 Performance Briefing
Follow Beijing Foyou Pharma into a list and get an email when it puts out news.
Follow Beijing Foyou Pharma